Medication Brand Names Beginning with ‘D’

Page 1 of 549 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

D-Care 100X (Lidocaine Hydrochloride, Povidone-Iodine, Isopropyl Alcohol)

Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional…

RX PHARMA-PACK, INC.31 January 2020

D-Penamine (Penicillamine)

Dear Health Care Provider: Due to the shortage of penicillamine titratable tablets in the United States (U.S.) market. Mylan is coordinating with the U.S. Food and Drug Administration…

Mylan Pharmaceuticals Inc.13 November 2018

D.H.E. 45 (Dihydroergotamine Mesylate)

D.H.E. 45 (dihydroergotamine mesylate) Injection USP is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes…

Valeant Pharmaceuticals North America6 November 2017

D.H.E. 45 (Dihydroergotamine Mesylate)

D.H.E. 45 (dihydroergotamine mesylate) Injection USP is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes…

Bausch Health US, LLC1 November 2019

Dabigatran Etexilate

Dabigatran Etexilate Capsules is a direct thrombin inhibitor indicated: To reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (1.1) For the…

Ascend Laboratories, LLC12 March 2020

Page 1 of 549 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error
Sun, 20 Sep 2020. Three of the recalls, which BD announced on Aug. 4, 2020, have been designated as Class I recalls by the U.S. Food and Drug Administration (FDA), which means that FDA has determined that there is a reasonable probability that the use of the product…
Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency
Wed, 16 Sep 2020. Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.